Summary. N,N-Diethyl-2- [4-(phenylmethyl) 
Introduction
The effects of oestrogens on reproductive tract physiology appear to result from complex receptor interactions (Knowler & Beaumont, 1985) , involving both classical and alternative (non-genomic) pathways (Tchernitchin, 1983) , and to depend upon the activation of various intracellular second messengers such as cyclic AMP (Szego & Davis, 1967) and calcium (Pietras & Szego, 1975) . Similarly, the antioestrogenic/antiproliferative effects of tamoxifen may be multifactorial in origin (Jordan et ai, 1981) , since in addition to binding to the oestrogen receptor, this triphenylethylene derivative also interacts with microsomal antioestrogen binding sites (Murphy et ai, 1981) and antagonizes the action of calmodulin (Lam, 1984) , protein kinase C (O'Brien et ai, 1986) and calcium (Greenberg et ai, 1987) .
To determine a precise role for various pathways and their mediators in oestrogen/antioestrogen action, selective ligands are required. In this regard, a para-diphenylmethane derivative synthesized in our laboratory, N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine HC1 (DPPE), binds to antioestrogen binding sites with high affinity (Ki = 65 10~9 m) (Brandes & Hermonat, 1984) . Unlike tamoxifen, DPPE does not bind significantly to oestrogen receptors in rat uterine cytosol (Brandes & Hermonat, 1984) or antagonize the action of calmodulin (Brandes et ai, 1986) or protein kinase C (Brandes et ai, 1988 (Brandes et ai, 1987) its various actions cannot be attributed to calcium channel antagonism (Brandes et ai, 1987; Glavin & Brandes, 1988) .
In vitro, DPPE is antiproliferative at lower (1-10 µ ) concentrations and cytotoxic at higher (> 10 µ ) concentrations against both oestrogen receptor-positive and oestrogen receptor-negative breast cancer cells (Brandes, 1984; Brandes et ai, 1985) and augments similar effects of tamoxifen (Brandes, 1984) . In the immature, oophorectomized rat, DPPE alone has been demonstrated to decrease uterine weight below control values, unlike tamoxifen alone, which is a partial agonist. Like tamoxifen, however, DPPE antagonizes the growth-promoting effects of exogenous oestradiol , despite the fact that it does not compete for oestrogen receptors (Brandes & Hermonat, 1984) . These findings support an important role for antioestrogen binding sites in the mechanism of action of tamoxifen.
Studies of rat brain membranes (Brandes et ai, 1987) and human platelets (Brandes et ai, 1988; Saxena et ai, 1989; McNicol et ai, 1989) provide evidence that the DPPE/anti-oestrogen binding site is associated with an intracellular histamine receptor (HIC) of micromolar affinity, which is different from the classical H1 and H2 receptors and the H3 receptor (Schwartz et ai, 1986) . By binding at this site, newly-formed histamine functions as a second messenger for multiple agonists mediating platelet aggregation (Saxena et ai, 1989) and is implicated as a mediator of growth (Brandes et ai, 1987 (Brandes et ai, 1987 (Brandes et ai, , 1988 . The in-vitro antagonism of cell growth by DPPE is signifi¬ cantly reversed by L-histidine and L-methionine (Brandes et ai, 1987) , two amino acids involved in histamine metabolism, while in agonist-stimulated platelets the anti-aggregatory effect of DPPE is reversed in permeabilized, but not intact, cells by 0T-10pM-histamine, suggesting an action of DPPE on an intracellular histamine target of micromolar affinity (Saxena et ai, 1989 (Sigma, St Louis, MO, USA) were dissolved in 50% ethanol before dilution in saline (0-154 M-NaCl). The final effective ethanol concentration for oestradiol was 18-5%, while that for tamoxifen was 15%. DPPE was synthesized as described previously (Brandes & Hermonat, 1984) To assess the effects of saline, oestradiol (100 pg/kg), DPPE (4 mg/kg or 1-25 10~5 mol/kg) or tamoxifen (0-65 mg/kg, or 115 10"6 mol/kg) alone on uterine size and histology, groups of animals received the various agents once daily for 3 days. After dissection and weighing, uteri were stored in formalin until histological study.
The effects on uterine size and histology of saline, DPPE, tamoxifen, or tamoxifen + DPPE were compared when each was administered 1 h before oestradiol for 3 days. A higher dose of oestradiol (300 pg/kg) was chosen for these experiments in an attempt to obtain maximal stimulation for histological assessment, especially pertinent to eosinophil migration (Tchernitchin, 1983) . To assess possible synergism between DPPE and tamoxifen, two doses of tamoxifen were used, an optimal dose of 0-65mg/kg and a low dose of 004mg/kg (71 10~8mol/kg). The latter dose results in substantially decreased, although still significant, oestrogenic and antioestrogenic action in the rat uterus, compared with the optimal dose of tamoxifen (Allen et a!, 1980) . The dose of DPPE remained constant (4 mg/ kg) allowing comparison of additive effects of DPPE to the optimal and low doses of tamoxifen.
Histological studies
For histological studies. 4 paraffin wax-embedded transverse sections, cut at different levels, were prepared identi¬ cally for all uteri, stained with haematoxylin and eosin, and assessed microscopically by one individual (G.R.H.).
For luminal epithelium, height (pm) and the number of mitotic figures were assessed. To measure accurately the height of luminal epithelium, only cells with the best orientation, showing no artefactual distortion on a thin basement membrane complex, were included. Such cells were found to be present in small strips and to be uniform in size and appearance. For glandular epithelium, the number of mitotic figures was assessed. In the luminal and glandular epithelia, the mitotic figure count per section included only those cells in which mitosis was definitely recognizable.
For each uterus, the total number of eosinophils (stroma plus circular muscle layer)/section was counted. Measurement of eosinophilia was confined to the entire endometrial stroma and circular muscle, as infiltration was noted to be most dense at the interface of these structures. Artefactual damage at the level of the serosa and longi¬ tudinal muscle occurred frequently enough to preclude accurate assessment; therefore estimation in these areas was not included.
In some experiments, microscopic cross-sectional area of uteri was roughly estimated by multiplying horizontal and vertical diameters, as measured by micrometer.
Statistical analysis
Effects on uterine weight. Significant differences in final body weight among treatment groups may of themselves influence uterine weight (Lyman & Jordan, 1985) . However, the maximal difference observed in final body weight among the treatment groups was only 5%. Analysis of covariance, to adjust for final body weight, had no effect on statistical significance for any group. Therefore, analysis of variance of the unadjusted mean uterine wet weights was applied over all four treatment groups (Table 2) , or all 6 treatment groups (Table 3) , as well as over a sub-set of 3 treatment groups (Table 2) or of 5 treatment groups (Table 3 ) excluding the oestradiol (or saline + oestradiol) group, since the effect of oestrogen treatment on the uterine response was deemed predictable from previous results (Katzenellenbogen et ai, 1981; . Since all F ratios from the ANOVA were found to be significant at ¡ 001, Fisher's Restricted (Protected) Least Significant Difference test (Snedecor & Cochran, 1980) was then applied.
Effects on uterine histology. To determine significant effects among treatment groups on each parameter of uterine histology, analysis of variance (ANOVA) for multiple comparison protection, as above, and Fisher's Restricted L.S.D. test were used. For analysis of mitosis in luminal and glandular epithelium, as well as numbers of eosinophils, for which the standard deviations were proportional to the mean counts, indicating unequal variances, and the counts themselves were, in some groups, very low, a log transformation, ln (x + 0-05), was applied to stabilize the variances before the subsequent analysis.
Results

Dose-response of DPPE
The optimal daily dose of DPPE to antagonize oestradiol stimulation of uterine growth over 72 h was 4 mg/kg (Fig. 1) , with lesser, but significant, effects at 2 mg/kg and 8 mg/kg. At 4 mg DPPE/kg, the uterine wet weight was 77-2 + 3-8 mg (mean ± s.e.m.), while that for controls was 99-4 + 4-3 mg ( < 0001). At doses below 2 mg/kg and above 8 mg/kg, DPPE did not signifi¬ cantly antagonize oestradiol. However, despite the bell-shaped dose-response curve for DPPE in the presence of oestradiol, when tested alone over a wide daily dosage range, DPPE did not increase uterine size above control (saline alone); on the contrary, at all dosages from 01 to 75 mg/kg, DPPE treatment resulted in significantly (P < 005) smaller uteri than in saline-treated controls (Fig. 2) Comparison of antagonism of oestradiol action on uteri at 72 h The uteri of oestradiol-treated animals receiving the antioestrogens were all significantly smaller than those of the corresponding saline controls (Table 2 ). No significant difference in uterine wet weight was observed between DPPE and tamoxifen groups in the same set of experiments. A significant difference (P < 005) was observed for the combined DPPE + tamoxifen (0-65 mg/kg) group compared with DPPE alone, but not compared with tamoxifen (0-65 mg/kg) alone (Table  2A) . When the tamoxifen dose was reduced (004mg/kg) the value for combined DPPE + tamoxifen treatment did differ significantly (P < 005) from that of tamoxifen alone (Table 2B) .
The effect of the various treatments on uterine histology is shown in Table 3 . In the presence of oestradiol, DPPE-treated animals consistently had the lowest luminal epithelial height, but the value was significantly ( < 0001) different only from that of animals receiving 0-65 mg tamoxifen/kg. Treatment with DPPE + 0-65 mg tamoxifen/kg resulted in a significantly higher epithelial height than in saline-treated animals (P < 0-001) but a significantly lower height than in animals treated with 0-65mg tamoxifen/kg alone (P < 005).
Only the DPPE group failed to demonstrate significant inhibition of luminal epithelial mitosis. While a dose-response was observed for the two concentrations of tamoxifen, DPPE did not aug¬ ment either dose to inhibit luminal epithelial mitosis. In contrast to its lack of inhibitory effect on Values without a superscript letter in common are significantly different values).
(P < 005 at least; see text for actual the oestradiol-stimulated luminal epithelium, DPPE, like tamoxifen, significantly antagonized mitotic activity in the glandular epithelium (Table 3 ). The combination of DPPE + 004mg tamoxifen/kg was significantly more inhibitory to mitosis in glandular epithelium than was the Downloaded from Bioscientifica.com at 09/20/2019 08:10:38PM via free access same dose of either alone (P < 002). However, the greatest inhibition of glandular epithelium was observed with 0-65 mg tamoxifen/kg. A significant decrease in oestradiol-stimulated uterine eosinophilia was seen for DPPE and both tamoxifen alone groups compared with controls (Table 3) , and the decrease was more marked with both the combined treatments.
Discussion
The results confirm our earlier observations that the selective antioestrogen binding site ligand DPPE decreases uterine size and weight when given alone, and antagonizes the effects of exogenous oestradiol on the uterus in the immature oophorectomized rat . Previously, a single-ringed compound (BPEA) with affinity for antioestrogen binding sites, but not for oestrogen receptors, was reported to be inactive in vivo (Sheen et ai, 1985 (Brandes & Hermonat, 1984) .
It may be argued that DPPE is not really antioestrogenic in the true sense, but simply exerts a generalized negative antiproliferative effect on cells and tissues, including the uterus, in the absence or presence of oestrogen. However, several findings make this unlikely: (a) unlike its inhibitory effect on both the oestradiol-stimulated and unstimulated uterus, DPPE administration under the same conditions had no significant effect on the wet weight of the liver, spleen and kidneys, all of which contain antioestrogen binding sites (Kon, 1983) ; and (d) DPPE selectively antagonized the growth-promoting effects of oestradiol on the uterine glandular but not luminal epithelium.
Although the bell-shaped dose-response curve for DPPE in the presence of oestradiol suggests a partial agonist action, none was seen. The shape of the curve is similar to that observed for histamine reversal of the anti-aggregatory effects of DPPE in permeabilized platelets (Saxena e? ai, 1989 (Jordan et ai, 1981) , DPPE could antagonize the pituitary-hypothalamic axis. Further studies are required to elucidate the exact mechanism by which DPPE causes uterine atrophy in oophorectomized animals.
While some effects of DPPE on uterine histology differ from, others are similar to, those of tamoxifen. For example, whereas tamoxifen inhibited oestradiol-stimulated luminal epithelial proliferation and, at its optimal dose (0-65 mg/kg), caused significant hypertrophy of luminal epithelium in the presence of oestradiol, DPPE had no such effect, although in the presence of oestradiol it significantly decreased tamoxifen-induced epithelial hypertrophy. On the other hand, it was observed that both DPPE and tamoxifen inhibited oestradiol-stimulation of glandular epi¬ thelial proliferation, with the combination of DPPE and low-dose (004 mg/kg) tamoxifen demon¬ strating significantly additive effects. The greater potency of the optimal dose of tamoxifen to inhibit glandular epithelium may result from its 12-fold higher affinity for antioestrogen binding sites compared with DPPE (Brandes & Hermonat, 1984) . Finally, although both DPPE and tamoxifen alone antagonized oestradiol-stimulated uterine eosinophil content, their combined inhibitory action on uterine eosinophilia was greatest. Whether this effect is due to an interaction at the level of the eosinophil itself (Tchernitchin, 1983) , or an effect of DPPE and tamoxifen to alter the production of chemotactic or other factors in the uterus, remains to be determined.
In summary, while the actions of DPPE and tamoxifen differ both qualitatively and quanti¬ tatively in certain fundamental respects, nevertheless DPPE specifically antagonizes oestradiol stimulation of uterine growth, of eosinophil migration and of glandular epithelial proliferation. Moreover, the combination of DPPE and a low dose of tamoxifen is significantly more inhibitory than either alone. As DPPE interacts with antioestrogen binding sites/HIC receptors, but not with oestrogen receptors, this could indicate that binding to the former site(s) is also important to the overall mechanism of action of tamoxifen.
Some years ago, it was recognized that the ring (triphenylethylene) structure of tamoxifen is related to known oestrogens and the aliphatic constituent to known (H,) antihistamines (Harper, 1967) , but its effects to prevent implantation could not be mimicked by traditional H, antagonists (Harper, 1965) . We suggest that, like DPPE, tamoxifen acts at the antioestrogen binding/HIC site, rather than at an H ! extracellular site (Spaziani & Szego, 1959; Szego, 1965) to antagonize histamine. As previously demonstrated in the kidney (Maeyama et ai, 1985) , oestrogen could activate histidine decarboxylase in the uterus, with newly formed histamine functioning as an intracellular second messenger to mediate some oestrogen action.
